neural stem cells expressing E. coli cytosine deaminase
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for neural stem cells expressing E. coli cytosine deaminase, covering 2017-11-09 to 2017-11-09. Get the full timeline:
Most recent: Clinical Trial Update: A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas [Phase 1]